T. Aschenbrenner
Max-Planck-Institut
für extraterrestrische Physik, D - 85748 Garching, Germany
Introduction
Membrane models have turned out to be the relevant
ingredients for the simulation of electrical activity of cardiac tissue
on small scales. Based on a set of specific membrane channels and associated
ionic currents with a complicated, nonlinear dynamics, they give a reliable,
in a wide range of experimental situations well tested microscopic description
of electrical activity. Of course, membrane models could, in principle,
be the starting point for the simulation of e.g. a complete ventricle;
the enormous amount of computer power required, however, renders this approach
rather impractical.
Cellular automaton models of the electrical activity, in contrast, are
computationally very efficient. The rules they are based on, however, usually
are cartoon-like representations of the properties of excitable media or,
at most, are applicable only in a very specific situation.
In this paper, the hybrid method is presented: This approach
tries to combine the precision and flexibility of the membrane models with
the computational efficiency of CAs. For this purpose a (quasi)one-dimensional
tissue of cells, based on the membrane model of Luo and Rudy [2],
is studied under a variety of situations. The results of these simulations
are translated into situation-dependent rules for the CA. In this way,
the CA receives a physiologically justified foundation and allows - within
the limited range of situations - the realistic simulation of the electrical
activity on larger scales; even, as shown here, the electrical behaviour
of the whole human heart - with its activation and repolarisation patterns,
surface potentials, ECGs - is accessible to simulation. In addition, the
effects of drugs that modify the dynamics of membrane channels can easily
be implemented in this scheme. The hybrid method allows to study the variation
of the ECG under the influence of e.g. class I antiarrhythmia.
The Hybrid Method
In this section the hybrid method to simulate the
electrical activity of the heart is demonstrated. For this purpose the
following situation is studied as an example: It is assumed that the sinoatrial
node (SAN) stimulates periodically and that the heart has reached a "stationary"
periodic state characterized by the stimulation period, the basic cycle
length (BCL). Now, the electrical response of the heart to an "aperiodic"
stimulus i.e. a stimulation by the SAN with a cycle length thist
differing from BCL, is investigated. Obviously, this is a "one-parameter-family
of situations" labeled by thist. To be precise, since the periodic
and aperiodic excitations propagate with different velocities, thist
will in general be a locally varying quantity.
Appropriate simulations with a linear chain of membrane model
cells (details see below) and a variety of thist values are
conducted and the results obtained are processed suitably: It turns out
that the electrical response, the action potential (AP) and its velocity
of excitation can satisfactorily be described by a general shape formula
with five thist-dependent parameters (normalized results).
There arises a slight complication, which in addition is accounted
for within the hybrid method. Typical electrical parameters
of the AP (normal situation: no drugs, basic cycle length BCL=1000 ms,
that means a heart frequency of F=1 Hz.) depends on the location in the
heart. However, the corresponding adjustments of the Luo and Rudy membrane
model are not known or at least not published.
Therefore, it is assumed here that the local behaviour may be described
by a thist-independent deformation of the linear chain results.
These deformations are defined by rescaling the normalized parameters such
that at thist=BCL they are equal to those typical parameters
given in textbooks.

Figure 1: Scheme of the hybrid method
The Linear Chain
For the membrane model, the Luo and Rudy model of the electrical activity
of single ventricular cells [2] is chosen.
Beside the fast inward sodium current INa, whose formulation
was in the main focus of this model, a secondary inward, a slow calcium
current and four outward potassium currents are represented. The equations
of the different ionic currents are of the Hodgkin-Huxley [3]
type.
To include drug effects, e.g. the effects of class I antiarrhythmia,
the formulation of the fast sodium inward current has to be modified. Here,
the "guarded receptor model" by Starmer et al. [4]
is incorporated. With this, an additional equation for the relative number
b of blocked sodium channels has to be solved:
|
|
db
dt |
= k D · (1-h) · (1-b)-L ·b
|
|
(1) |
D denotes the concentration of the drug, k the association rate of the
drug to the sodium channel and L the analogous dissociation rate. h describes
the inactivation gate of the sodium channel. The sodium current in the
presence of an antiarrhythmic drug<(p>
shows a use-dependent behaviour: The relative number of blocked channels
b increases during the course of an action potential and decays exponentially
thereafter. A higher frequency of excitation - in other words a lower basic
cycle length BCL - leads to an increased number of blocked sodium channels.
To investigate the behaviour of collective phenomena, a small tissue
sample has to be built with the Rudy and Luo cells. According to physiology
the cell-to-cell coupling is ohmic. The simplest choice is a (quasi)one-dimensional
medium: the linear chain. To avoid boundary effects, a special protocol
is used for the computer experiments:
Figure 2: Coupling procedure used by the computer experiments with
the linear chain.
We split the configuration in three chains. In the beginning chain A
and B are coupled (symbolized by Kab). Cell #1 is stimulated
N times with a fixed basic cycle rate BCL=1000 ms. (N has to be large enough
to get "stationary conditions" for this value of BCL.) This leads to N
waves of excitation in the direction of cell #270. The Nth stimulation
of cell #1 is associated with t=0. At a certain time t=t* cell
#271 is stimulated leading to a wave of excitation in the direction of
#330. If the transmembrane potential of #300 is greater than that of cell
#31, then chain A and B are uncoupled and C and B are linked together (Kcb),
so that - instead of #301 - cell #31 is adjacent to #300.
The results refer to the N+1st stimulation of the central part (cells
#60 to #240) of chain B. The behaviour of these cells strongly depends
on the individual last cycle length thist, that is the actual
individual time difference to the last excitation. The cell's response
to the excitation is in general an action potential (AP) which propagates
with a certain velocity v. The shape of the AP may well be characterized
by the following parameters:
peak,
the peak value of the AP, tpeak the duration of the fast upstroke
(phase 0) of the AP,
plateau,
the value of the transmembrane potential
M
during the plateau phase and tref, the duration of the AP.
For a BCL=1000 ms the parameters concerning the shape of the AP and
the velocity v are displayed as functions of thist in figs.
3 and 4 respectively. In these figures, the
results for three different situations are plotted: Squares label the simulation
with normal model parameters, that means the original Luo and Rudy model
coupled to a one-dimensional medium. Triangles mark the case where the
maximum sodium conductivity is reduced by 66%; this is approximately the
sodium conductivity, which is effective in the case of the class I antiarrhythmic
drug (BCL=1000 ms, kD=4.0 Hz, L=0.5 Hz) at thist=1000 ms. The
simulations with this class I antiarrhythmic drug are symbolized by circles.
Figure 3: The influence of the cycle length thist on
the characteristic parameters of the AP. Squares label the simulation with
normal parameters. Circles represent the results with the class I drug
(kD=4.0 Hz, L=0.5 Hz) and triangles the case with the reduced sodium conductivity
(by 66%).
Figure 4: The influence of the cycle length thist on
the (normalized) propagation velocity of the excitation wave. Squares label
the simulation with normal conditions. Circles represent the velocities
with the class I drug and triangles the case with the reduced sodium conductivity.
As expected the curves for the class I drug and of the reduced sodium
conductivity cross at about thist=1000 ms. All of the class-I-drug-associated
curves show the use dependent behaviour, the feature of recovery for longer
cycle lengths. A simple reduction in sodium conductance is inappropriate
to mimic the effects of class I drugs.
The Cellular Automaton (CA)
In this section, a short description of the components of the CA (geometry,
neighborhood, states, rules) will be given.
A data set of the geometry of a real human heart was made available
by Dr. Meinzer from the German Cancer Research Center (DKFZ). According
to these data, approximately 90000 model-cells are arranged on a cubic
array with a grid spacing g = 0.15 cm. To account for the parameter variations
of the heart cells (typical parameters), the different regions of the heart
(atria, ventricles) and specific structures (sinoatrial node, atrioventricular
node, specific conducting system, isolating layer between atria and ventricles)
had to be identified manually. The condition for the neighborhood is a
distance smaller or equal to
.
In the CA, the cells take one of the following three states: During
the quiescent state (I), the transmembrane potential is equal
to the resting membrane potential, the
active state (II)
marks the starting point of the AP and the refractory state (III)
covers the whole course of the AP: upstroke, plateau phase and the complete
recovery.
A graphical representation of the rules of the CA is given in Figure
5.
Figure 5: Flow diagram for the state evolution of a single cell
in the cellular automaton. Assignments are symbolized by rectangles, ovals
mean queries. If one condition is met, the vertical line is the path to
follow. See text.
A more detailed description of the rules can be found elsewhere
[1].
quiescent state (I): If a cell is in the quiescent state,
the value of the counter history, this corresponds to the cycle
length, will be increased by one. An excitation, a change from the quiescent
state to the active state, is only possible if a certain time since
the last AP has elapsed and the membrane potential of the neighboring cells
exceeds a certain threshold. The value of Errmax determines
the number of timesteps the cell has to stay in state I; this controls
the velocity of excitation.
Active state (II): The cell changes in the refractory
state.
Refractory state (III): This state is divided in two parts,
in the absolute refractory state and the relative refractory state, governed
by the number of timesteps (Refrak) elapsed in this state (relative
to Refrakmax). Only in the second time period a cell's
state could be changed to the active one. For this, conditions similar
to transition I to II have to be met.
The Determination of the Actual Parameters
For every model cell, the number of timesteps since the last excitation
(history in figure 7) determines the thist-value and
using the simulations with the linear chain the corresponding characteristic
parameters. These parameters are modified depending on the location of
the heart (as mentioned above).
These actual parameters are then used to calculate the membrane potential
depending on the value of Refrak, which is given by the CA.
So, the CA uses the results of the linear chain to compute for every
timestep and cell the value of the transmembrane potential. With this and
certain assumptions (quasistationarity, bidomain model, infinite torso
model), the extracardial potential can be related to the Laplacian of the
transmembrane potential (see review of Gulrajani [5]).
The positions of the electrodes on the "surface" of the infinite torso
are chosen according to Thiry and Rosenberg [6].
As all cells of the model heart are assumed to behave like ventricular
cells, there is no automaticity built in in this model: A "heartbeat" has
to be initiated "manually" by changing the state of the cells representing
the sinoatrial node to the active state.
Results
A simulation under normal conditions ( thist=1000
ms, no drug, normal electrical parameters) shows the basic properties of
this computer model.
Figure 6: Simulation of the standard-12 ECG with normal electric
parameters.
A comparison of the duration of the simulated P-Wave with typical values
yields a time resolution of
= 0.15
ms.
The simulated standard-12 ECG (e.g. right axis deviation) resembles
ECGs of enlarged right chambers. These were the reasons to check again
the geometric properties of the heart model: It seems, that the geometric
data were derived from a right hypertrophic human heart.
Another point of interest is the simulated sequence of excitation and
repolarisation. In figures 7 and 8, these electrical events are shown color
coded on slices of the model heart. The upper left (lower right) slice
corresponds to the most (least) distant portion of the heart (frontal perspective).
Figure 7: Isochrones of activation for normal parameters from a
frontal perspective. Lead V3 is displayed at the bottom.
Figure 8: Isochrones of repolarisation for normal parameters from
a frontal perspective. Lead V5 is displayed at the bottom.
The Isochrones of activation are defined by the time (relative to SAN),
when the cells are in the active state. Similarly, the isochrones of repolarisation
are defined by the transition refractory to quiescent state. The sequence
of excitation (figure 7) complies well with the description given by Durrer
et al. [7]. In addition the repolarisation
patterns are in satisfactory agreement with the qualitative behaviour given
in the literature [8,9]:
The ventricular cells are activated first, which are located on the endocardial
layers of the heart exhibit the longest refractory periods and repolarise
at the very end of the repolarisation sequence and vice versa.
Atrial cells have more or less a constant refractory period; therefore,
their isochrones for activation and repolarisation look quite similar.
Now, the influence of the cycle length (thist) as well as
drug effects on the electrical activity of the whole heart model, expressed
by the ECG is demonstrated. To get the influence of the cycle length on
the different components (waves, intervals, segments) these structures
have to be identified. This is done by visual inspection of the lead V6
and its time derivative.
As examples, the PQ segment, the QRS complex and the QT interval are
selected: The duration of each of these structures as a function of the
cycle length thist is displayed. This is done for three cases
(analogous to the simulations with the linear chain): The results with
normal model parameters are labeled with squares. Triangles mark the case
where the maximum sodium conductivity is reduced by 66% (for motivation
see text above).
The simulations with the class I antiarrhythmic drug are
symbolized by circles.
Figure 9: Duration of the PQ segment tPQ as a function
of the cycle length thist. For the explanation of the symbols,
see figure 3 or 4.
Figure 10: Duration of the QRS complex tQRS as a function
of the cycle length thist. For the explanation of the symbols,
see figure 3 or 4.
Figure 11: Duration of the QT interval tQT as a function
of the cycle length thist. The parallel lines mark the curve
tQTnormal, max = (thist)0.5
· 0.42 s (with thist in seconds), the maximal value of
normal QT intervals for fixed cycle lengths, that means steady state conditions.
For the explanation of the symbols, see Figure 3
or 4.
In presence of the antiarrhythmic drug, the PQ interval is enlarged
by 51%; this is mainly the effect of the increased PQ segment (79%). The
very slight enlargement of the QT interval (+4%) stems from the increased
QRS duration (+17%). The JT interval keeps its value constant.
These results with the hypothetical class I drug, at least for steady
state conditions (cycle length thist=1000 ms), are consistent
with "clinical properties" of class Ic drugs: Class Ic medicaments increase
markedly the P-R interval [10,11]
and (even at low concentration) the duration of the QRS complex
[10,11,12]
but the duration of the J-T interval is almost not changed
[10,12].
Conclusions
In this paper, a new method is presented which
fills the gap between membrane models and cellular automata approaches
to the simulation of electrical activity. With the hybrid method the rules
of the CA get a quantitative justification. So effects, which could be
simulated with membrane models on small tissue samples are "translated"
with the hybrid method to the electrical activity of whole heart models.
Here, the effects of the cycle length and of a (hypothetical) class
I drug on the electrical activity of the whole heart are simulated. But
this method is not restricted to class I medicaments: any effect which
can be implemented in membrane models is a possible candidate for the hybrid
method.
I just want to add a few comments to this model:
This membrane model is only valid for ventricular cells. As soon as membrane
models for other types of cells (atrial cells, nodal cells, cells of the
SCS, etc.) are available this restraint could be overcome.
All the results are produced for a basic cycle length BCL=1000 ms. Only
for this value of the cycle length ("stationary conditions"), medical textbooks
present sufficient data for comparison.
To cover a wider range of frequencies, all the simulations (membrane
model, CA) have to be conducted with other values of the BCL.
The real human heart, the geometric data set was derived from, seems to
exhibit right hypertrophic properties.
Acknowledgments
Financial support by the Max-Planck-Gesellschaft is gratefully acknowledged.
References
[1] Aschenbrenner, T., "Simulation der Wirkung
von Medikamenten auf das Elektrokardiogramm am Beispiel von Klasse I-Antiarrhythmika",
(München, Techn. Univ., Diss., 2000), Der Andere Verlag, 2000.
[2] Luo, C.-H. and Rudy, Y., "A model of the ventricular
cardiac action potential depolarization, repolarization, and their interaction",
Circulation Research, vol. 68, no. 6, pp. 1501-1526, 1991.
[3] Hodgkin, A. L. and Huxley, A. F., "A Quantitative
Description of Membrane Current and its Application to Conduction and Excitation
in Nerve", Journal of Physiology, vol. 117, pp.500-544, 1952.
[4] Starmer, C. F., Lastra, A. A., Nesterenko,
V. V. and Grant, A. O., "Proarrhythmic response to sodium channel blockade
- theoretical model and numerical experiments", Circulation, vol. 84, pp.
1364-1377, 1991.
[5] Gulrajani, R. M., "Models of the electrical
activity of the heart and computer simulation of the electrocardiogram",
CRC Critical Reviews in Biomedical Engineering, vol. 16, no. 1, pp. 1-66,
1988.
[6] Thiry, P. S. and Rosenberg, R. M., "On
electrophysiological activity of the normal heart", Journal of the Franklin
Institute, vol. 297, pp. 377-396, May 1974.
[7] Durrer, D., van Dam, R. T., Freud, G. E., Janse,
M. J., Meijler, F. L. and Arzbaecher, R. C., "Total excitation of the isolated
human heart", Circulation, vol. 41, pp. 899-912, June 1970.
[8] Burgess, M. J., Green, L. S., Millar, K., Wyatt,
R. and Abildskov, J. A., "The sequence of normal ventricular recovery",
American Heart Journal, vol. 84, no. 5, pp. 660-669, Nov. 1972.
[9] van Dam, R. T., and Durrer, D., "Experimental
study on the intramural distribution of the excitability cycle and on the
form of the epicardial T wave in the dog heart in situ", American Heart
Journal, vol. 61, pp. 537-542, 1961.
[10] Somberg, J. C., "Clinical use of class
Ic antiarrhythmic drugs", in Antiarrhythmic Drugs, E. M. Vaughan Williams
and T. J. Campbell, Eds., vol. 89 of Handbook of Experimental Pharmacology,
chapter 11, pp. 235-277. Springer Verlag, 1989.
[11] Gülker, H., Haverkamp, W. and Hindricks,
G., "Leitfaden zur Therapie der Herzrhythmusstörungen", de Gruyter,
2 edition, 1992.
[12] Vaughan Williams, E. M., "Classification
of antiarrhythmic actions", in Antiarrhythmic Drugs, Vaughan Williams,
E. M. and Campbell, T. J., Eds., vol. 89 of Handbook of Experimental Pharmacology,
chapter 2, pp. 45-67. Springer Verlag, 1989.